Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by forhandlaren

V.SBM

RE:RE:Pet Deal benchmark

Not neccessarily. The competitors might choose TFC-039 to take on Elanco. It...

October 24, 2022

V.SBM

RE:RE:RE:Sirona as a buyout target

Dear biorun, I think most of us appreciate the science the company is built...

October 18, 2022

V.SBM

Financing Operating Costs

The company needs about 2 million USD in revenue per year to break-even, not...

October 18, 2022

V.SBM

RE:share price

Pre-disclosure of Abbvie up-front I would agree, but now I'm not so sure....

October 17, 2022

V.SBM

RE:Responsibility Howard Verrico

I have a rather substantial investment so I really need the company to be...

October 17, 2022

V.SBM

RE:Responsibility Howard Verrico

In my experience the management has stopped communicate with shareholders a...

October 17, 2022

V.SBM

RE:RE:RE:RE:Allergan Aesthetics to Present Data

I'm not totally conviced yet. The Spot TX video says that about 68 per...

October 10, 2022

V.SBM

RE:Where do we go from here?

The start of the anti-aging clinical trial is clearly a major achievement...

October 6, 2022

V.SBM

Any CEO update?

The CEO quarterly update is due, will be interesting to see if they take the...

October 5, 2022

V.SBM

RE:Licensing agreement uncertainty

To be fair, we don't know the full extent of the deal. It could include a...

October 4, 2022

V.SBM

RE:Irrational meets rational

1) In theory I agree, but based on what's known about the two last deals...

October 4, 2022

V.SBM

RE:Share Price Support

The first move by the company should be to end the inflated hype and...

October 3, 2022

V.SBM

RE:RE:Fundamental issue

Realistic expectations is key. Building a hype not fulfilled kills the share...

October 2, 2022

V.SBM

RE:RE:Fundamental issue

Michelle is responsible for the anticipated next deal - diabetes treatment if...

October 1, 2022

V.SBM

RE:RE:Fundamental issue

Seems like only Geraldine contribute with value among management...

October 1, 2022

V.SBM

Fundamental issue

I've interacted with many doctors on a social basis over the year. One...

October 1, 2022

V.SBM

RE:RE:Investor Call required

Recall that the former CEO Neil Belenkie offered calls with investors on a...

September 29, 2022

V.SBM

RE:Investor Call required

I support the idea of an investor call, very good initiative! Any normal...

September 29, 2022

V.SBM

RE:Sirona Press Release

The ultimate goal for the company is to maximize the value of an exit down...

September 29, 2022

V.SBM

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:What’s going on?

The purpose of additional warrants/options issued to management is to achive...

September 27, 2022

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Biosenta Inc.

Biosenta Inc. C.ZRO

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and ... view more »